A Biparatopic Antibody That Modulates MET Trafficking Exhibits Enhanced Efficacy Compared with Parental Antibodies in MET-Driven Tumor Models - Concepedia

Concepedia

Publication | Closed Access

A Biparatopic Antibody That Modulates MET Trafficking Exhibits Enhanced Efficacy Compared with Parental Antibodies in MET-Driven Tumor Models

30

Citations

45

References

2019

Year

John O. DaSilva, Katie Yang, Andrés E. Perez Bay, Julian Andreev, Peter Ngoi, Erica Pyles, Matthew C. Franklin, Drew Dudgeon, Ashique Rafique, Anthony Doré,

Clinical Cancer Research

Abstract

Our results provide strong support for the notion that biparatopic antibodies are a promising therapeutic modality, potentially having greater efficacy than that predicted from the properties of the parental antibodies.

References

	Year	Citations

Page 1